Stocks Surge Midday: Accenture Soars 18%, Synopsys Rises Over 8%, United Therapeutics Jumps 6% Following Court Ruling

Accenture's stock surged 18% after reporting fiscal fourth-quarter revenue of $18.7 billion, surpassing both its guidance and analyst expectations. McCormick's adjusted earnings of 86 cents per share exceeded forecasts, yet its stock fell over 2% amid an ongoing acquisition by Unilever.

McKesson's shares rose 4% after reaffirming its fiscal 2027 earnings guidance and extending a partnership with CVS Health. A federal court ruling favored United Therapeutics, leading to a 6% increase in its shares, while Liquidia's stock dropped 15% due to the ruling's negative implications for its lung treatment.

Constellation Energy's shares climbed nearly 3% following a long-term deal with Amazon, and Synopsys shares jumped over 8% after outlining a growth strategy and announcing a partnership with OpenAI. Sigma Lithium's shares fell 16% after suspending production due to legal delays, while Acuity Brands saw a nearly 4% drop after providing lower-than-expected sales growth guidance.

BJ's Restaurants' stock rose about 5% following an upgrade from Mizuho, and Vicor's shares surged almost 10% after raising its revenue growth forecast. Corteva's spinoff of its Vylor business resulted in an 84% plunge for the remaining company shares after a court ruling allowed the separation to proceed

Stocks in this article

Company Price Change Change % AI
Accenture ACN.US 216.61 +33.24 +18.13% Buy
Synopsys SNPS.US 495.25 +60.31 +13.87% Buy
McKesson Corporation MCK.US 892.44 +38.63 +4.52% Buy
Constellation Energy CEG.US 260.43 +6.41 +2.52% Hold
CVS Health CVS.US 85.45 -0.24 -0.28% Hold
Amazon AMZN.US 249.67 +0.52 +0.21% Hold

More business news